Last updated: February 15, 2024
Sponsor: Pharos University in Alexandria
Overall Status: Active - Recruiting
Phase
2/3
Condition
Pharyngitis
Treatment
Topical dexamethasone
10% lidocaine was sprayed over the tube for the second group
Clinical Study ID
NCT06266481
pua04202312313157
Ages 18-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- •Patients belonging to ASA physical status I, II
- Patients between age18 to 50 years
- Patients belonging to both genders.
- patients undergoing shoulder arthroscopic surgeries.
- Patients with fasting blood glucose <100 mg/dl or random blood sugar <140mg/dl.
Exclusion
Exclusion Criteria:
- Patients who are not willing to give consent for participation in the study
- Patients with anticipated difficult airway
- Patients who are allergic to steroids.
- Patients with ASA physical status III, IV
- Diabetic patients.
- Patients on steroids
- Patients requiring nasogastric tube or throat pack.
- Patients posted for head and neck surgeries.
- patient with GERD
- Pregnant patients
- preexisting upper respiratory tract infection.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Topical dexamethasone
Phase: 2/3
Study Start date:
March 01, 2024
Estimated Completion Date:
May 30, 2024
Study Description
Connect with a study center
Pharos University
Alexandria, 21348
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.